Expression levels of matrix metalloproteinase-2 (MMP-2) and MMP-9 can be utilized as biomarkers to assess the metastatic potential of ovarian cancer and the invasiveness of breast cancer cells [83, 84]. This evidence concerns the gene MMP9 and ovarian cancer.